Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |